(Q46429285)

English

Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

scientific article published on 14 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

0 references

author name string

Yoshiyuki Hattori

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Kunihiro Suzuki

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Atsuko Tomizawa

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Noriko Hirama

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Toshie Okayasu

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Sachiko Hattori

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Hiroko Satoh

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Kazumi Akimoto

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Kikuo Kasai

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

publication date

14 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Cardiovascular Research

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

81

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

133-139

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

AMP-activated protein kinase signaling in metabolic regulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Impact of cilostazol on clinical and angiographic outcome after primary stenting for acute myocardial infarction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Vascular smooth muscle cell activation by glycated albumin (Amadori adducts).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Analysis of the cilostazol safety database

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Cilostazol as a Unique Antithrombotic Agent

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

The AMP-activated protein kinase pathway--new players upstream and downstream.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1093/CVR/CVN226

Identifiers

10.1093/CVR/CVN226

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18703532

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46429285&oldid=2114268965"